[go: up one dir, main page]

NO20015206L - Renin inhibitorer - Google Patents

Renin inhibitorer

Info

Publication number
NO20015206L
NO20015206L NO20015206A NO20015206A NO20015206L NO 20015206 L NO20015206 L NO 20015206L NO 20015206 A NO20015206 A NO 20015206A NO 20015206 A NO20015206 A NO 20015206A NO 20015206 L NO20015206 L NO 20015206L
Authority
NO
Norway
Prior art keywords
renin inhibitors
renin
inhibitors
Prior art date
Application number
NO20015206A
Other languages
English (en)
Other versions
NO20015206D0 (no
NO320803B1 (no
Inventor
Volker Breu
Hans-Peter Maerki
Eric Vieira
Wolfgang Wostl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20015206D0 publication Critical patent/NO20015206D0/no
Publication of NO20015206L publication Critical patent/NO20015206L/no
Publication of NO320803B1 publication Critical patent/NO320803B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyridine Compounds (AREA)
NO20015206A 1999-04-27 2001-10-25 Renin-inhibitorer, fremstilling av disse, fremstilling av preparater, samt anvendelse for fremstilling av medikamenter. NO320803B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99108199 1999-04-27
PCT/EP2000/003555 WO2000064873A1 (en) 1999-04-27 2000-04-19 Renin inhibitors

Publications (3)

Publication Number Publication Date
NO20015206D0 NO20015206D0 (no) 2001-10-25
NO20015206L true NO20015206L (no) 2001-10-25
NO320803B1 NO320803B1 (no) 2006-01-30

Family

ID=8238050

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015206A NO320803B1 (no) 1999-04-27 2001-10-25 Renin-inhibitorer, fremstilling av disse, fremstilling av preparater, samt anvendelse for fremstilling av medikamenter.

Country Status (35)

Country Link
US (2) US6376672B1 (no)
EP (1) EP1175400B1 (no)
JP (1) JP3808706B2 (no)
KR (1) KR100443684B1 (no)
CN (1) CN1147471C (no)
AR (2) AR018719A1 (no)
AT (1) ATE512949T1 (no)
AU (1) AU763718B2 (no)
BR (1) BR0010080B1 (no)
CA (1) CA2370888C (no)
CO (1) CO5170513A1 (no)
CZ (1) CZ302012B6 (no)
DK (1) DK1175400T3 (no)
EG (1) EG23979A (no)
ES (1) ES2366668T3 (no)
GC (1) GC0000251A (no)
HK (1) HK1045999B (no)
HR (1) HRP20010762A2 (no)
HU (1) HU227764B1 (no)
IL (2) IL146002A0 (no)
JO (1) JO2256B1 (no)
MA (1) MA26787A1 (no)
MX (1) MXPA01010934A (no)
MY (1) MY127894A (no)
NO (1) NO320803B1 (no)
NZ (1) NZ514981A (no)
PE (1) PE20010069A1 (no)
PL (1) PL199895B1 (no)
PT (1) PT1175400E (no)
RS (1) RS51156B (no)
RU (1) RU2213731C2 (no)
TR (1) TR200103095T2 (no)
TW (1) TWI224593B (no)
WO (1) WO2000064873A1 (no)
ZA (1) ZA200108735B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
US6835686B2 (en) * 2001-07-05 2004-12-28 Millennium Specialty Chemicals Catalyst system and process for rearrangement of epoxides to allylic alcohols
JP2005532371A (ja) * 2002-06-27 2005-10-27 アクテリオン　ファマシューティカルズ　リミテッド レニン阻害剤としての新規なテトラヒドロピリジン誘導体
US20040214832A1 (en) * 2003-04-10 2004-10-28 Cuiman Cai Piperazine derivative renin inhibitors
BRPI0409881A (pt) * 2003-04-29 2006-05-23 Actelion Pharmaceuticals Ltd compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
TW200900399A (en) * 2003-10-01 2009-01-01 Speedel Experimenta Ag Organic compounds
AR045950A1 (es) * 2003-10-09 2005-11-16 Speedel Experimenta Ag Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos.
WO2005037317A2 (en) * 2003-10-17 2005-04-28 Cornell Research Foundation, Inc. Mast cell-derived renin
DE602004022704D1 (de) * 2003-11-26 2009-10-01 Novartis Ag 4-phenylpiperidinderivate als renininhibitoren
TW200613274A (en) * 2004-07-09 2006-05-01 Speedel Experimenta Ag Organic compounds
CN101102755B (zh) 2004-10-08 2013-01-02 诺瓦提斯公司 肾素抑制剂在制备预防或治疗舒张功能障碍或舒张性心力衰竭的药物中的用途
GB0428526D0 (en) 2004-12-30 2005-02-09 Novartis Ag Organic compounds
GB0500784D0 (en) * 2005-01-14 2005-02-23 Novartis Ag Organic compounds
EP1707202A1 (de) * 2005-03-31 2006-10-04 Speedel Experimenta AG Organische Verbindungen
BRPI0609534A2 (pt) * 2005-03-31 2010-04-13 Speedel Experimenta Ag piperidinas 3,4,5-substituìdas
ES2352564T3 (es) * 2005-03-31 2011-02-21 Novartis Ag Piperidinas sustituidas.
TW200722424A (en) * 2005-03-31 2007-06-16 Speedel Experimenta Ag Substituted piperidines
EP1897879A3 (en) * 2005-03-31 2008-06-11 Speedel Experimenta AG 2,4,5-substituted piperidines as renin inhibitors
AR055756A1 (es) * 2005-03-31 2007-09-05 Speedel Experimenta Ag Piperidinas sustituidas; procesos de preparacion y su uso como medicamentos
KR100963455B1 (ko) 2005-05-27 2010-06-18 액테리온 파마슈티칼 리미티드 신규한 피페리딘 카르복실산 아미드 유도체
GB0514203D0 (en) * 2005-07-11 2005-08-17 Novartis Ag Organic compounds
AU2006304836A1 (en) * 2005-10-21 2007-04-26 Novartis Ag Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
CN101356156B (zh) * 2005-11-14 2012-12-05 生命医药公司 天冬氨酸蛋白酶抑制剂
ES2430139T3 (es) * 2005-12-30 2013-11-19 Novartis Ag Compuestos de piperidina 3,5-sustituido como inhibidores de renina
EP1816122A3 (en) * 2006-01-19 2007-09-19 Speedel Experimenta AG 3,4,5-substituted piperidines as therapeutic compounds
TW200804359A (en) * 2006-01-19 2008-01-16 Speedel Experimenta Ag Substituted 4-phenylpiperidines
TW200821303A (en) * 2006-08-08 2008-05-16 Speedel Experimenta Ag Organic compounds
WO2008021552A2 (en) * 2006-08-18 2008-02-21 Duke University Biased ligands and methods of identifying same
EP1911758A1 (en) * 2006-10-04 2008-04-16 Speedel Experimenta AG Phenyl piperidine derivatives for use as renin inhibitors
EP1908761A1 (en) * 2006-10-04 2008-04-09 Speedel Experimenta AG Organic compounds
EP2181105B1 (en) 2007-06-25 2015-04-29 Novartis AG N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
TW200934499A (en) * 2007-11-02 2009-08-16 Speedel Experimenta Ag 4,4-disubstituted piperidines
US10517839B2 (en) 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
US8728984B2 (en) 2009-10-14 2014-05-20 Rainer Oberbauer Acute kidney injury risk testing
WO2013045505A1 (en) 2011-09-28 2013-04-04 Novartis Ag Biomarkers for raas combination therapy
EP2810644A1 (en) 2013-06-06 2014-12-10 Ferrer Internacional, S.A. Oral formulation for the treatment of cardiovascular diseases
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868181A (en) * 1986-08-04 1989-09-19 E. I. Du Pont De Nemours And Company 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
DK231088D0 (da) 1988-04-28 1988-04-28 Ferrosan As Piperidinforbindelser, deres fremstilling og anvendelse
DE3640475A1 (de) 1986-11-27 1988-06-09 Hoechst Sa Lab Arzneimittel auf basis von derivaten des 3,4-diphenylpiperidins, die verwendung der derivate als arzneimittel sowie neue 3,4-diphenylpiperidinderivate und verfahren zu ihrer herstellung
EP0594618B1 (en) 1991-06-24 1996-04-24 B.V. Optische Industrie "De Oude Delft" Device for measuring the respiration of a person
WO1997003911A1 (de) 1995-07-24 1997-02-06 Railfix N.V. Elektro-permanentmagnetsystem zum manövrieren von einer magnetischen insbesondere ferromagnetischen last
KR100384979B1 (ko) * 1995-09-07 2003-10-17 에프. 호프만-라 로슈 아게 심부전증및신부전증치료용의신규한4-(옥시알콕시페닐)-3-옥시-피페리딘
WO1999012532A2 (en) * 1997-09-08 1999-03-18 F.Hoffmann-La Roche Ag Piperidine derivatives against malaria
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors

Also Published As

Publication number Publication date
US6376672B1 (en) 2002-04-23
PL199895B1 (pl) 2008-11-28
RU2213731C2 (ru) 2003-10-10
TR200103095T2 (tr) 2002-04-22
CO5170513A1 (es) 2002-06-27
CZ20013854A3 (cs) 2002-04-17
HUP0203669A3 (en) 2003-12-29
PL353442A1 (en) 2003-11-17
US20020087002A1 (en) 2002-07-04
HU227764B1 (en) 2012-02-28
TWI224593B (en) 2004-12-01
RS51156B (sr) 2010-10-31
DK1175400T3 (da) 2011-07-18
JP2002543063A (ja) 2002-12-17
AR070473A2 (es) 2010-04-07
CA2370888C (en) 2005-08-23
HRP20010762A2 (en) 2005-02-28
AR018719A1 (es) 2001-11-28
CA2370888A1 (en) 2000-11-02
IL146002A (en) 2007-03-08
NO20015206D0 (no) 2001-10-25
WO2000064873A1 (en) 2000-11-02
PE20010069A1 (es) 2001-03-03
GC0000251A (en) 2006-11-01
HK1045999B (zh) 2004-10-21
CN1147471C (zh) 2004-04-28
YU77101A (sh) 2004-09-03
EP1175400B1 (en) 2011-06-15
PT1175400E (pt) 2011-08-11
BR0010080B1 (pt) 2012-03-20
ES2366668T3 (es) 2011-10-24
IL146002A0 (en) 2002-07-25
NZ514981A (en) 2004-02-27
EG23979A (en) 2008-02-27
HUP0203669A2 (hu) 2003-02-28
ZA200108735B (en) 2003-01-23
MXPA01010934A (es) 2002-05-06
JO2256B1 (en) 2004-10-07
ATE512949T1 (de) 2011-07-15
CZ302012B6 (cs) 2010-09-08
KR20010109529A (ko) 2001-12-10
AU4296800A (en) 2000-11-10
NO320803B1 (no) 2006-01-30
KR100443684B1 (ko) 2004-08-09
AU763718B2 (en) 2003-07-31
HK1045999A1 (en) 2002-12-20
MY127894A (en) 2006-12-29
JP3808706B2 (ja) 2006-08-16
EP1175400A1 (en) 2002-01-30
CN1349503A (zh) 2002-05-15
US6673931B2 (en) 2004-01-06
BR0010080A (pt) 2002-01-15
MA26787A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
ATE512949T1 (de) Reninhemmer
DE60035039D1 (de) Renin inhibitoren
PT1181017E (pt) Inibidores de metaloproteases
PT1224195E (pt) C-aril-glicosidos inibidores de tgls2
ATE285821T1 (de) Fab i inhibitoren
EE200100492A (et) Ensüümi IMPDH inhibiitorid
PT1194404E (pt) Inibidores de aspartil-protease
ATE524441T1 (de) Vla-4-inhibitoren
EE200200069A (et) Metalloproteinaaside inhibiitoriteks olevad pürimidiin-3,4,6-trioonid
DE60008527D1 (de) Zellproliferation inhibitoren
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
NO20014243L (no) Dihetero-substituerte metalloproteaseinhibitorer
IS6413A (is) Setnir 8-arýkínólín fosfódíesterasa-4 latar
NO20021658L (no) Asfaltenhemmere
NO20014875D0 (no) Promedikamenter for trombin inhibitorer
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
DE60024101D1 (de) Enzyminhibitoren
DE60009260D1 (de) Thiopyranderivate as mmp-inhibitoren
NO20022924L (no) Farnesyltransferase-inhibitorer
AR028075A1 (es) Inhibidores de la peptido-desformilasa
EP1234581A4 (en) WOUND-contraction INHIBITOR
IDP000027420A (id) Inhibitor-inhibitor kinase pirolotriazin

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees